Menstrual Disorders Study Guide Flashcards

(37 cards)

1
Q

1st Line Tx for Dysmenorrhea

A

NSAIDs (Naproxen is best)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2nd Line Tx for Dysmenorrhea

A

Oral contraceptives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3rd Line Tx for Dysmenorrhea

A

Medroxyprogesterone (MPA) (DepoProvera); or Levonorgestrel IUD (Mirena)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

OCP MoA for Tx of Dysmenorrhea

A

Reduces s/sx by inhibiting proliferation of endometrial tissue, leading to reduced prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Trial period required for evaluation of OCP in tx of dysmenorrhea

A

Trial of 2-3 months necessary to determine effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Medroxyprogesterone MoA

A

Inhibits secretion of gonadotropins&raquo_space; prevention of ovulation&raquo_space; endometrial thinning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Medroxyprogesterone Side Effects

A

Amenorrhea after several months of tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tx options for Menorrhagia

A

OCP; Mirena; Progesterone therapy (Provera)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Timing for Provera Effectiveness in Tx of Menorrhagia

A

Start during luteal phase of menstrual cycle, or for 21 days starting on day 5 of cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

1st Line Tx for Endometriosis

A

Combination OCPs or IM Medroxyprogesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2nd Line Tx for Endometriosis

A

GnRH analogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3rd Line Tx for Endometriosis

A

Danazol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Potential AE for Medroxyprogesterone

A

Bone density loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GnRH Agonist Limitations

A

Only for use in patients older than 16; limit to 6 months of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GnRH Agonist Adverse Effect

A

Bone density loss (use progestin or progestin/estrogen combo as add-back therapy); May cause a temporary increase in pain during initial therapy for endometriosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GnRH Agonists

A

Leuprolide (Lupron Depot); Goserelin (Zoladex); Nafarelin (Synarel);

17
Q

Leuprolide (Lupron Depot) Route

18
Q

Leuprolide (Lupron Depot) Adverse Effects

A

Hot flashes; Amenorrhea; HA, Depression; Bone loss

19
Q

Leuprolide (Lupron Depot) Monitoring

A

Bone density; Pregnancy prior to initiation

20
Q

Goserelin (Zoladex) Route

A

Implant sub-Q every 28 days

21
Q

Nafarelin (Synarel) Route

A

Nasal sol’n

22
Q

Danazol (Danocrine) Class & MoA

A

Androgen - suppresses output of LH & FSH&raquo_space; regression/atrophic of NL & ectopic endometrial tissue

23
Q

Danazol (Danocrine) Pregnancy Category

24
Q

Danazol (Danocrine) Black Box

A

Thromboembolism; Intracranial HTN; Hepatitis & Hepatic adenoma; r/o preg prior to tx

25
Danazol (Danocrine) Disadvantages
Avoid in hyperlipidemia/liver dz/preg; High rate of adrogenic side effects
26
Tx options for PMS & PMDD
SSRIs, SNRIs; Tricyclics; OCPs; GnRH Agonists; Diuretics; NSAIDs
27
1st Line Tx for PMS & PMDD
SSRIs. Fluoxetine (Sarafem/Prozac) preferred.
28
SSRI with Preg Category D
Paroxetine (Paxil)
29
2nd Line Tx for PMS & PMDD
SNRI - Venlafaxine (Effexor XR); or TCA - Clomipramine, Elavil
30
AE of Venlafaxine (Effexor)
^ BP & HA with abrupt withdrawal
31
Preferred OCPs for PMS or PMDD
Drospirenone-containing products (Yaz, Yasmin; Beyaz)
32
Adverse Effects of Drospirenone-Containing OCPs
Thromboembolism; HA; peripheral edema; hyperkalemia
33
Diuretic for PMS or PMDD tx
Spironolactone (Aldactone)
34
Spironolactone MoA
Aldosterone antagonist; relieves breast tenderness & fluid retention
35
Timing of spironolactone tx
Given during luteal phase
36
Major AEs of Danazol
^ LFTs & ^ lipids
37
Major AE of GnRH Agonists
^ risk of osteoporosis